has anyone died from compounded semaglutide The FDA received reports of adverse events after patients used versions of semaglutide. Some compounders may also be using unapproved salt forms. Patients should avoid compounded when an FDA-approved Drugmakers battle pharmacies over compounded

Dermatologic reactions linked to GLP-1 therapy are gaining attention as the use of glucagon-like peptide-1 receptor agonists continues to expand in diabetes and obesity care

Diabetes and obesity are considered risk factors, in addition to heart disease, high blood pressure, and other conditions affecting hormone balance, such as hyperthyroidism

A second reason TRIUMPH-1 matters more: the 80-week duration

That sounds contradictory

For semaglutide, Novo Nordisk filed the composition patent in December 2003 (issued as US 8,927,488 in 2015), giving a base expiration of December 2023

It also impacts your vaginal tissues, urinary tract, and skin